Navigation Links
New Special Edition Oreck(R) Vacuum Helps Clean for the Cure(R)
Date:9/9/2009

NASHVILLE, Tenn., Sept. 9 /PRNewswire/ -- The Oreck vacuum was invented with women in mind, according to Oreck Corporation founder David Oreck. "That's why I engineered it to be lightweight and powerful for ease of use, effective cleaning and allergen control," Oreck said.

"In our support of Susan G. Komen for the Cure in the fight against breast cancer, we designed two new special edition vacuums to help raise donations for the cause," Oreck said.

October is national Breast Cancer Awareness Month. "For every pink-accented Clean for the Cure(R) special edition Oreck XL bagged vacuum purchased, Oreck will donate $25 to Komen for the Cure," Oreck said. "To date Oreck Corporation donated more than $1 million to Komen for the Cure to search for the cure for breast cancer," reported Oreck. "That puts us in the top 25 percent of donors to Susan G. Komen for the Cure."

Susan G. Komen for the Cure is the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.

The Clean for the Cure Oreck vacuums with disposable inner bags are fashionably black with pink piping, pink ribbon zipper fob charm, a pink base and have advanced filtration as well as Oreck's antibacterial IntellaShield Technology(TM).

"It is our hope that anyone needing a new or additional vacuum will think of the importance of supporting the breast cancer cause and think pink," Oreck said. "Susan G. Komen for the Cure is clearly a cause that touches our consumers and we want to give back to the people who buy our products."

Lightweight yet powerful, Oreck vacuums are engineered for allergen control with a multi-layer hypo-allergenic filtration system and an advanced, patented self-sealing disposable inner bag. The filtration system eliminates 99.9 percent of allergens down to .3 microns (bacteria measures .4 to 10 microns), including bacteria, aller
'/>"/>

SOURCE Oreck Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
7. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
10. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
11. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... have found evidence of a statistically significan...atients whose estrogen receptor (ER)-positive tumo... at serine-118 (ER-alpha S118-P), according to a b... the Journal of the National Cancer Institute . ,...stant to tamoxifen. Preclinical studies have shown...
(Date:11/25/2009)...low-up period was too short to draw definite concl.... 25 (HealthDay News) -- In diabetic patients with... difference in outcomes at one year whether patien...ting, British researchers report. , Bypass surg...atients with coronary artery disease. However, les...
(Date:11/25/2009)...etfulness could lead mothers to overlook needed ca...HealthDay News) -- A mother,s depression can worse... , Their six-month study of 262 black mothers a...s had more depressive symptoms had more frequent a...er depressive symptoms had less frequent asthma sy...
(Date:11/25/2009)...RK,Nov.25/PRNewswire/-- MISSIONSkincare ®ispr...rSt.Jude.AspartofGNC,sannualSt.Jude ThanksandGivin...incare,s new SUPER-C(TM)LipBalm willbedonatedtoS...tomakea$1,$5or$10donationatcheckoutatoneoftheir5,0...han$1millionforSt.Judeduringtheir2009 ThanksandGiv...
(Date:11/25/2009)...Mass. -- A cancer vaccine carried into the body on...is the first to successfully eliminate tumors in m... Science Translational Medicine . , The new app... at Harvard University, uses plastic disks impregn...der the skin to reprogram the mammalian immune sys...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... Reynolds American,Inc. (NYSE: RAI ) will webcast...d-quarter 2008 financial results on Wednesday, Oct... Time., During the call, members of the Reynolds ...le online on a listen-only basis,at http://www.Re...
... "air burial," grave cairns, funeral mounds, mummi...ces sacred to one culture are often considered "od... example, were fascinated with the historian Herod...ontrary to the Greeks, treatment of their own dead...
...al concerns surrounding use of cells from embryos ...European researchers say they,ve figured out how t...onic-like stem cells. , The findings are the lates...acles associated with their use. , "The ability to...
...The National,Community Pharmacists Association (NC...-term incumbent representing North Carolina, for r... executive vice president and CEO of,NCPA, issued ...serve. That is why the,National Community Pharmaci...
...The National,Community Pharmacists Association (NC...m incumbent representing Arkansas, for re-election... vice president and CEO of NCPA,issued the followi...e National,Community Pharmacists Association stron...
...The National,Community Pharmacists Association (NC...rm incumbent representing Kansas, for re-election ...vice president and CEO of NCPA,issued the followin...National,Community Pharmacists Association strongl...
Other Medicine News:Health News:RAI to Webcast Third-Quarter 2008 Earnings Conference Call 2Health News:Deathways open doors to unexpected cultural practices 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 3Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 4
(Date:11/25/2009)....25/PRNewswire/--SwissrayInternational,Inc.aleadin...ems,announcedtodaythatitsoperationshavebeenacquire...owingSwissray,smedicalimagingbrand.Theacquisitioni...ntractsandinventory.After25yearsofsuccessandgrowth...icaladvancementswithstableandsteadygrowth. ,, "...
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...v.25/PRNewswire/-- ChemoCentryx,Inc.,announcedtod...CT-1(theProspectiveRandomizedOralTherapyEvaluation...npatientswithmoderate-to-severeCrohn,sdiseasedemon...rabilityprofile.Thestudydemonstratedevidenceofclin...edasa70-pointdecreaseintheCrohn,sDiseaseActivityIn...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5SXC Health Solutions announces pricing of upsized public offering of common shares 57606 1SXC Health Solutions announces pricing of upsized public offering of common shares 57606 2SXC Health Solutions announces pricing of upsized public offering of common shares 57606 3SXC Health Solutions announces pricing of upsized public offering of common shares 57606 4SXC Health Solutions announces pricing of upsized public offering of common shares 57606 5AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 1AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 1Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 3
...--Apr 17, 2007 - A 9-month, randomized,double-bli...omparing a 40 mg dose of COPAXONE(R) given daily t...owed a 38 percent greater,reduction in inflammator...ce images (MRI) of the brain. In addition, patient...ean on-trial relapse rate,of 77 percent when compa...
...erican Association for Cancer Research,annual meet...-FirstCall/ --,Medarex, Inc. today presented precl...ity from two separate studies exploring the,effica...ti-CD70,antibody-drug conjugates. CD19 and CD70 ar...jugate approach to cancer therapy. They are,expres...
Other Medicine Technology:Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4
MP20
... IntelliVue MP90 is designed to match the pace and...nts. Built on Philips strong heritage in patient m...nt displays has highly flexible screen configurati...-in clinical support tools such as Event Surveilla...
...xNet adds wireless capability to Welch Allyn's com... the Flexible Monitoring concept to provide vital ...o anywhere. FlexNet links multiple devices such as...reless bedside monitors to Acuity® Central Mon...
Spot Vital Signs
Medicine Products: